Gene · 5792
PTPRF: protein tyrosine phosphatase receptor type F
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. PTPRF: protein tyrosine phosphatase receptor type F. Genes, record 5792. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/5792
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P10586 | Receptor-type tyrosine-protein phosphatase F | 1,907 | 13 | Ensembl, GeneID, HGNC |
Source UniProt
Patents40
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 60137 | P10586 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 60139 | P10586 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 7731 | P10586 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 7776 | P10586 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 11133 | P10586 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 3639 | P10586 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 7501 | P10586 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 3639 | P10586 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 7501 | P10586 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 7776 | P10586 | Espacenet |
1 to 10 of 40
See all 40 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,312
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | PTPRF papers | Newest fiscal year |
|---|---|---|---|
| P30CA016672 | Cancer Center Support Grant | 21 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 17 | 2025 |
| R01CA069202 | Structure/Function of Protein Tyrosine Phosphatases | 11 | 2025 |
| P30CA068485 | Cancer Center Support Grant | 10 | 2025 |
| P50CA058223 | SPORE in Breast Cancer | 7 | 2025 |
| P40OD010440 | Caenorhabditis Genetics Center | 6 | 2025 |
| P30CA016086 | Cancer Center Support Grant | 5 | 2025 |
| P30CA125123 | Baylor College of Medicine Cancer Center - Cancer Center Support Grant | 5 | 2025 |
| R01CA053840 | Protein Tyrosine Dephosphorylation & Signal Transduction | 5 | 2025 |
| U54GM104940 | Louisiana Clinical and Translational Science Center | 5 | 2025 |
1 to 10 of 1,312Source NIH's project files
See all 1,312 nih grantsPapers2,345
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Incremental Prognostic Value of Albumin-Anchored Inflammatory Ratios Beyond a SOFA-Based Model in a Medical ICU: A Retrospective Cohort Study. | Metabolites | 2026 | 42783817 | PubTator, text mining | PubMed |
| Out of the blue: family-wide loss of anthocyanin biosynthesis in Cucurbitaceae. | Plant J | 2026 | 42781862 | PubTator, text mining | PubMed |
| Ternary Neurexin-T178-PTPR complexes represent a pre-synaptic core-module of neuronal synapse organization. | Nat Commun | 2026 | 42701130 | PubTator, text mining | PubMed |
| Lactate to albumin ratio LAR predicts mortality in critically ill adults with asthma across two cohorts. | Sci Rep | 2026 | 42665605 | PubTator, text mining | PubMed |
| Prognostic value of albumin-related inflammatory ratios for 30-day mortality in rheumatic heart disease: a dual-cohort study with external validation. | Front Nutr | 2026 | 42661627 | PubTator, text mining | PubMed |
| Exosome-Related Pathogenic Genes in Adenomyosis: A Multi-Omics Mendelian Randomization Study. | OMICS | 2026 | 42610667 | PubTator, text mining | PubMed |
| Development and Validation of a Prediction Model for Early ARDS in Children with Sepsis in the PICU: A Multicenter Retrospective Cohort Study. | J Multidiscip Healthc | 2026 | 42604193 | PubTator, text mining | PubMed |
| Association of Early Postoperative Biochemical Markers with a Composite Adverse Perioperative Outcome After Bariatric Surgery. | Diagnostics (Basel) | 2026 | 42587570 | PubTator, text mining | PubMed |
| Immunohistochemistry-based molecular subtypes and stromal tumor-infiltrating lymphocytes in triple-negative breast cancer: a chemotherapy-only cohort. | Oncologist | 2026 | 42587422 | PubTator, text mining | PubMed |
| Modulating phosphorylation by proximity-inducing strategy: an update. | RSC Med Chem | 2026 | 42582980 | PubTator, text mining | PubMed |
1 to 10 of 2,345
See all 2,345 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/5792
GET https://conductscience.org/api/genes/v1/5792/patents?page=2